Overview
Akie Kobayashi practices in Hirosaki, Japan. Kobayashi is rated as an Advanced expert by MediFind in the treatment of Pure Red Cell Aplasia. Their top areas of expertise are Aase Syndrome, Leukemoid Reaction, Pure Red Cell Aplasia, and Hereditary Neuroblastoma.
Their clinical research consists of co-authoring 15 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Pure Red Cell Aplasia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Aase SyndromeKobayashi isAdvanced. Learn about Aase Syndrome.
- Hereditary NeuroblastomaKobayashi isAdvanced. Learn about Hereditary Neuroblastoma.
- Leukemoid ReactionKobayashi isAdvanced. Learn about Leukemoid Reaction.
- Pure Red Cell AplasiaKobayashi isAdvanced. Learn about Pure Red Cell Aplasia.
- Experienced
- Acute Interstitial PneumoniaKobayashi isExperienced. Learn about Acute Interstitial Pneumonia.
- AnemiaKobayashi isExperienced. Learn about Anemia.
- Aplastic AnemiaKobayashi isExperienced. Learn about Aplastic Anemia.
- Childhood Acute Myeloid LeukemiaKobayashi isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- D-Minus Hemolytic Uremic SyndromeKobayashi isExperienced. Learn about D-Minus Hemolytic Uremic Syndrome.
- D-Plus Hemolytic Uremic SyndromeKobayashi isExperienced. Learn about D-Plus Hemolytic Uremic Syndrome.